Secondary Logo

Journal Logo

October 2010 - Volume 33 - Issue 5
pp: 427-531


Is it Possible to Increase pCR in the Neoadjuvant Treatment With a Dose-Dense/Sequential Combination?: Results From a Phase II Trial Combining Epirubicin and Cyclophosphamide Followed by Paclitaxel and Gemcitabine ± Trastuzumab in Stage II and III Breast Cancer Patients

Sánchez-Muñoz, Alfonso; Dueñas-García, R.; Jaén-Morago, A.; More

American Journal of Clinical Oncology. 33(5):432-437, October 2010.


Irinotecan Plus Bolus/Infusional 5-Fluorouracil and Leucovorin in Patients With Pretreated Advanced Pancreatic Carcinoma: A Multicenter Experience of the Gruppo Oncologico Italia Meridionale

Gebbia, Vittorio; Maiello, Evaristo; Giuliani, Francesco; More

American Journal of Clinical Oncology. 33(5):461-464, October 2010.


Head & Neck





A Phase II Trial of Imatinib Mesylate in Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin): A Southwest Oncology Group Study (S0331)

Samlowski, Wolfram E.; Moon, James; Tuthill, Ralph J.; More

American Journal of Clinical Oncology. 33(5):495-499, October 2010.